Forsta AP Fonden Sells 3,000 Shares of MetLife, Inc. (NYSE:MET)

Forsta AP Fonden trimmed its position in MetLife, Inc. (NYSE:MET) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 195,700 shares of the financial services provider’s stock after selling 3,000 shares during the period. Forsta AP Fonden’s holdings in MetLife were worth $16,024,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Foster Victor Wealth Advisors LLC grew its position in MetLife by 2.6% in the 4th quarter. Foster Victor Wealth Advisors LLC now owns 163,515 shares of the financial services provider’s stock worth $14,190,000 after purchasing an additional 4,074 shares in the last quarter. Smith Group Asset Management LLC bought a new stake in MetLife in the 4th quarter worth about $2,456,000. R Squared Ltd bought a new stake in MetLife in the 4th quarter worth about $56,000. BSW Wealth Partners bought a new stake in MetLife in the 4th quarter worth about $215,000. Finally, Stonegate Investment Group LLC grew its position in shares of MetLife by 24.9% during the 4th quarter. Stonegate Investment Group LLC now owns 8,022 shares of the financial services provider’s stock valued at $657,000 after acquiring an additional 1,598 shares during the period. 94.99% of the stock is owned by institutional investors.

MetLife Stock Performance

NYSE MET opened at $86.77 on Thursday. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $60.08 billion, a PE ratio of 17.49, a P/E/G ratio of 0.65 and a beta of 1.07. The company’s 50 day simple moving average is $83.95 and its two-hundred day simple moving average is $80.30.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.51%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio is presently 43.95%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MET. Barclays increased their target price on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, January 6th. Piper Sandler increased their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. TD Cowen increased their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, JPMorgan Chase & Co. raised their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.46.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.